Researchers aim to modify the fragmented health system to reduce the incidence of HIV among trans women


HIV prevention services will be combined with access to gender-based hormone therapy and peer-to-peer healthcare to try to reduce the disproportionate percentage of transgender women who are HIV-positive in an innovative study led by researchers at the Science Center. the University of Texas Health in Houston (UTHeath).

“It ‘s important that we make sure we are complying with the needs of transgender women in Houston as they have one of the highest estimated HIV prevalences of any key population, ”said Jordan E. Lake, MD, senior researcher at the UTHealth site and associate professor of infectious diseases at McGovern Medical School at UTHealth. “A combined intervention that combines HIV prevention and hormone therapy services, which is supported by peers navigation, could significantly affect the HIV epidemic in this population. “

There are an estimated one million transgender adults living in the United States and an estimated 14% of transgender women live with HIV. Results of a 2011 survey of people in the US revealed that 28% of respondents had postponed the search due to previous experiences of discrimination.

Gender-based care and HIV prevention services require a personalized approach. When barriers to accessing care exist, access to critical care and sometimes life support can be jeopardized, and patients may have a higher risk of acquiring HIV than if these services would be readily available in a gender-affirming environment. Research has also shown a link between access to gender-affirming care and improvement .

The research team, which enrolls patients at Harris Health System’s Thomas Street Health Center, will measure the impact of a combined gender-based care intervention and prevention services, including pre-exposure prophylaxis. (PrEP) and testing and treatment for other people sexually. transmitted infections, a which are HIV negative.

“This study gives a lot facing stigma, discrimination, social rejection and exclusion, a way to access health care, employment and HIV prevention services among other available resources, ”said Byancha Lawson, a health browser for the study. ” Transgender people experience high rates of incarceration, , and violence, which are factors that affect their health and well-being, which puts them at high risk of acquiring HIV, ”Lawson said.

To be eligible for enrollment in the 18-month trial, participants must have an unknown HIV status or be HIV negative. Once HIV is tested and confirmed to be negative, patients will be randomized into one of two groups, immediate or delayed intervention. The immediate intervention group will be offered PrEP and hormone therapy that asserts gender in coordination with peer health browsing throughout the trial at the Thomas Street Health Center. Peer health browsers are individuals in the same community as the target population. They receive training to help guide patients through the health care system and reduce barriers to care.

Randomized individuals in the deferred intervention group will receive HIV prevention services through the study, but will be referred to other providers for care and case control that assert gender during the first six months of the trial. After these six months, they will receive the same combination plan as the immediate intervention group for the remainder of the trial.

Gender affirmative hormone therapy may not increase the risk of cardiovascular disease for transgender adolescents

Citation: Researchers aim to modify the fragmented health system to reduce the incidence of HIV in trans women (2021, May 21) recovered on May 21, 2021 at fragmented-health-hiv-incidence .html

This document is subject to copyright. Apart from any fair treatment for the purposes of private study or research, no part may be reproduced without written permission. Content is provided for informational purposes only.

Source link